|
|
Article: Cypher stent featured in more than 25 studies at the AHA meeting.
- Article from:
- Life Science Weekly
- Article date:
- December 7, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 DEC 7 - (NewsRx.com & NewsRx.net) -- Clinical data regarding the use of the Cypher Sirolimus-eluting Coronary Stent in treating challenging coronary lesions in a variety of patient populations were presented at the 2004 American Heart Association Scientific Sessions in New Orleans, Louisiana.
The Cypher Stent remains the most studied drug-eluting stent available today.
Among the more than 25 key Cypher Stent presentations at the international medical conference are results from the robust, international e-Cypher registry, which tracks use of the device in more than 15,000 patients; and studies that evaluate the Cypher Stent's performance in complex ...